Erratum for the Clinical and Translational Medicine “Multi-omics integration reveals the oncogenic role of eccDNAs in diffuse large B-cell lymphoma through STING signalling” by Zijuan Wu et al.
This article corrects the following:
-
Multi-omics integration reveals the oncogenic role of eccDNAs in diffuse large B-cell lymphoma through STING signalling
- Zijuan Wu,
- Wei Zhang,
- Luqiao Wang,
- Jiayan Leng,
- Yongle Li,
- Zhou Fan,
- Mengtao Zhan,
- Lei Cao,
- Yongning Jiang,
- Yan Jiang,
- Bing Sun,
- Jianxin Fu,
- Jianyong Li,
- Wenyu Shi,
- Hui Jin,
- Volume 14Issue 8Clinical and Translational Medicine
- First Published online: August 25, 2024
Zijuan Wu
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Search for more papers by this authorWei Zhang
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Department of Hematology, Suqian Hospital, Jiangsu Province Hospital, Suqian, China
Search for more papers by this authorLuqiao Wang
Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Search for more papers by this authorJiayan Leng
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China
Search for more papers by this authorYongle Li
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Search for more papers by this authorZhou Fan
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Search for more papers by this authorMengtao Zhan
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Search for more papers by this authorLei Cao
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Search for more papers by this authorYongning Jiang
Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
Search for more papers by this authorYan Jiang
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Search for more papers by this authorBing Sun
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Search for more papers by this authorCorresponding Author
Jianxin Fu
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
The Central Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China
Correspondence
Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.
Email: [email protected], [email protected] and [email protected]
Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Jianyong Li
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Correspondence
Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.
Email: [email protected], [email protected] and [email protected]
Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Wenyu Shi
Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
Correspondence
Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.
Email: [email protected], [email protected] and [email protected]
Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Hui Jin
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Correspondence
Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.
Email: [email protected], [email protected] and [email protected]
Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Email: [email protected]
Search for more papers by this authorZijuan Wu
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Search for more papers by this authorWei Zhang
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Department of Hematology, Suqian Hospital, Jiangsu Province Hospital, Suqian, China
Search for more papers by this authorLuqiao Wang
Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Search for more papers by this authorJiayan Leng
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China
Search for more papers by this authorYongle Li
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Search for more papers by this authorZhou Fan
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Search for more papers by this authorMengtao Zhan
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Search for more papers by this authorLei Cao
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Search for more papers by this authorYongning Jiang
Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
Search for more papers by this authorYan Jiang
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Search for more papers by this authorBing Sun
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Search for more papers by this authorCorresponding Author
Jianxin Fu
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
The Central Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China
Correspondence
Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.
Email: [email protected], [email protected] and [email protected]
Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Jianyong Li
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Correspondence
Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.
Email: [email protected], [email protected] and [email protected]
Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Wenyu Shi
Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
Correspondence
Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.
Email: [email protected], [email protected] and [email protected]
Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Hui Jin
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
Correspondence
Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.
Email: [email protected], [email protected] and [email protected]
Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Email: [email protected]
Search for more papers by this authorZijuan Wu. Clin Transl Med. 2024;14(8):e1807.
Following the publication of the original article,1 the authors identified minor errors in Figure 1C, where the images of one group was incorrect. Because during the image acquisition, we mistakenly labelled two duplicate results from a single sample. We have made the necessary corrections to Figure 1C. More importantly, we promise that the erratum has no impact on the conclusion and description of the article.
We apologize for this error.
REFERENCE
- 1Wu Z, Zhang W, Wang L, et al. Multi-omics integration reveals the oncogenic role of eccDNAs in diffuse large B-cell lymphoma through STING signalling. Clin Transl Med. 2024; 14(8):e1815. doi:10.1002/ctm2.1815
